AMRX Amneal Pharmaceuticals Inc

Price (delayed)

$17.92

Market cap

$5.72B

P/E Ratio

45.95

Dividend/share

N/A

EPS

$0.39

Enterprise value

$8.21B

?
Relative Growth: Rel. Growth: 78
Relative Strength: Rel. Strength: 93
Relative Valuation: Rel. Valuation: 74
Relative Profitability: Rel. Profitability: 55

Amneal Pharmaceuticals, Inc., headquartered in Bridgewater, NJ, is a fully-integrated pharmaceutical company focused on the development, manufacturing and distribution of generic and specialty drug products. The Company has operations in ...

Highlights
AMRX's quick ratio has soared by 91% YoY and by 6% from the previous quarter
The P/E is 87% below the last 4 quarters average of 349.0
AMRX's debt is up by 4.5% year-on-year

Key stats

What are the main financial stats of AMRX

AMRX stock price

How has the Amneal Pharmaceuticals stock price performed over time
Intraday
-0.28%
1 week
0.39%
1 month
3.76%
1 year
124%
YTD
42.22%
QTD
3.52%

Financial performance

How have Amneal Pharmaceuticals's revenue and profit performed over time
Revenue
$3.05B
Gross profit
$1.18B
Operating income
$435.52M
Net income
$122.12M
Gross margin
38.7%
Net margin
4%
The company's net income has surged by 69% QoQ
AMRX's net margin has surged by 67% since the previous quarter
The company's operating income rose by 21% YoY and by 11% QoQ
The company's gross profit rose by 13% YoY and by 6% QoQ

Price vs fundamentals

How does AMRX's price correlate with its fundamentals

Growth

What is Amneal Pharmaceuticals's growth rate over time

Valuation

What is Amneal Pharmaceuticals stock price valuation
P/E
45.95
P/B
N/A
P/S
1.86
EV/EBIT
22.8
EV/EBITDA
14.49
EV/Sales
2.7
The P/E is 87% below the last 4 quarters average of 349.0
AMRX's EPS has soared by 70% since the previous quarter
Amneal Pharmaceuticals's equity has surged by 66% YoY and by 36% QoQ
The price to sales (P/S) is 69% higher than the last 4 quarters average of 1.1
AMRX's revenue is up by 8% year-on-year

Efficiency

How efficient is Amneal Pharmaceuticals business performance
The company's return on assets has surged by 70% QoQ
AMRX's ROS is up by 27% year-on-year and by 10% since the previous quarter
AMRX's ROIC is up by 23% YoY and by 6% from the previous quarter

Dividends

What is AMRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AMRX.

Financial health

How did Amneal Pharmaceuticals financials performed over time
AMRX's quick ratio has soared by 91% YoY and by 6% from the previous quarter
The company's current ratio has surged by 76% YoY and by 14% QoQ
Amneal Pharmaceuticals's equity has surged by 66% YoY and by 36% QoQ
The company's debt to equity has shrunk by 56% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.